AVSF - Integrated Biosciences 2026, LLC has taken a significant step in its fundraising journey by filing a new offering under Rule 506(b). This filing, dated November 5, 2026, is crucial as it allows the company to raise capital while ensuring compliance with federal regulations.

AVSF - Integrated Biosciences 2026, LLC is a limited liability company incorporated in Delaware. The company operates in the venture capital fund sector, focusing on pooled investment funds. According to the recent filings, the company has a revenue range of $1 to $1,000,000 and is actively seeking to attract investors.

The filing states, "Rule 506(b) provides a 'safer harbor' for a private offering," emphasizing the regulatory framework supporting this fundraising effort. The company has already raised $261,500 from 18 investors, indicating initial interest in their offerings.

This move may affect various stakeholders, including potential investors looking for opportunities in the venture capital space. By adhering to federal exemptions, AVSF aims to attract accredited investors while maintaining compliance with the SEC's regulations.

The filing does not say what happens next, but the company’s ongoing efforts to raise funds could lead to further developments in the near future.

Company Overview and Management

AVSF - Integrated Biosciences 2026, LLC is managed by Alumni Ventures LLC, with Michael Collins serving as the Executive Officer and CEO. The company is incorporated in Delaware and operates from its business address in Manchester, New Hampshire, while its mailing address is located in Boston, Massachusetts.

The company has a fiscal year that ends on December 31st, and it is classified under the industry group of pooled investment funds, specifically focusing on venture capital funds.

Offering Details

The offering under Rule 506(b) is designed to attract accredited investors, and the minimum investment accepted is set at $5,000. The total amount raised so far is $261,500 from 18 investors, with the offering duration being less than one year and the total offering amount listed as indefinite.

Notably, there are no sales commissions or finders' fees associated with this offering, which may appeal to potential investors looking for a straightforward investment opportunity.

Future Considerations

The filing indicates that the company has not yet utilized any gross proceeds from the offering, and it remains to be seen how the raised funds will be allocated in the future. The absence of non-accredited investors suggests a focused strategy on attracting seasoned investors who can contribute to the company's growth.

"The filing emphasizes the regulatory framework supporting this fundraising effort, ensuring compliance while fostering investor confidence."